One Step Away from EU Market Compliance for NMN. The official positive opinion of Novel Food is expected to be published shortly, which means Uthever® NMN will be the first compliant ingredient. Meanwhile, Uthever® already secured FDA NDI clearance in the U.S., building a strong foundation for global compliance.
Visit us at VTF Europe and gain a first-mover advantage in the European market. Discover latest human clinical data of LipoAvail®, showing how liposomal technology improves bioavailability & supports better absorption.
Download White Paper to see Uthever®’s global compliance status, commercial advantages, & technical strengths.
